HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$28.18
Day range
$27.14 - $28.50
Year range
$25.99 - $51.61
Market cap
1.75B USD
Avg Volume
942.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 48.91M | 80.98% |
Net income | -43.42M | -69.27% |
Net profit margin | — | — |
Earnings per share | -0.72 | -24.14% |
EBITDA | -48.86M | -80.80% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 640.85M | 298.75% |
Total assets | 655.68M | 273.51% |
Total liabilities | 78.53M | 6.32% |
Total equity | 577.16M | — |
Shares outstanding | 63.75M | — |
Price to book | 3.10 | — |
Return on assets | -23.88% | — |
Return on capital | -25.06% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -43.42M | -69.27% |
Cash from operations | -39.18M | -55.83% |
Cash from investing | -221.38M | -1,293.05% |
Cash from financing | 325.96M | 1,212.85% |
Net change in cash | 65.39M | 258.50% |
Free cash flow | -26.36M | -62.20% |
About
Founded
2016
Headquarters
Website
Employees
112